Gamma linolenic acid inhibits tyrosine phosphorylation of focal adhesion kinase and paxillin and tumour cell matrix interaction

International Journal of Oncology

Volumn 8, Issue 3, 1996, Pages 583-587

  Jiang, W G ^a   Hiscox, S ^a   Puntis, M C A ^a   Hallett, M B ^a   Bryce, R P ^b   Horrobin, D F ^b   Mansel, R E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Scotia Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Cell adhesion; Focal adhesion kinase; Gamma linolenic acid; Integrin; Paxillin

Indexed keywords

FOCAL ADHESION KINASE; GAMMA LINOLENIC ACID; MATRIGEL; PAXILLIN;

ARTICLE; BREAST CARCINOMA; CELL ADHESION; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0029928947     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.3.583     Document Type: Article

References (39)

1. Begin ME, Ells G, Das UN, Horrobin DF: Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 77: 1053-1062, 1986.
2. Botha JH, Robinson KM, Ramchurren N, Norman RJ: The role of prostaglandins in the inhibition of cultured carcinoma cell growth produced by gamma-linolenic acid. Prostag Leukot Essent Fatty Acids 35: 119-123, 1989.
3. Begin ME, Ells G, Das UN and Horrobin DF: Polyunsaturated fatty acids induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 80: 188-194, 1988.
4. Hayashi Y, Fukushima S, Kishimoto S, Kawaguchi T, Numata M, Isoda Y, Hirano J, Nakano M: Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor. Cancer Res 52: 400-405, 1992.
5. Rose DP, Connolly JM, Meschter CL: Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83: 1491-1495, 1991.
6. Tiwari RK, Mukhopadhyay B, Telang NT, Osborne MP: Modulation of gene expression by selected fatty acids in human breast cancer cells. Anticancer Res 11: 1383-1388, 1991.
7. Takeda S, Horrobin DF, Manku M, Sim PG, Ells G, Simmons V: Lipid peroxidation in human breast cancer cells in response to gamma-linolenic acid and iron. Anticancer Res 12: 329-333, 1992.
8. Newman MJ: Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor beta is dependent on the presence of polyunsaturated fatty acids. Proc Natl Acad Sci USA 87: 5543-5547, 1990.
9. Horrobin DF: Essential fatty acids, lipid peroxidation, and cancer. In: Omega-6 essential fatty acids. Horrobin DF (Ed.), Wiley-Liss, New York, pp351-378, 1990.
10. Honn KV, Nelson KK, Renaud C, Bazaz R, Diglio CA, Timar J: Fatty acid modulation of tumor cell adhesion to microvessel endothelium and experimental metastasis. Prostaglandins 44: 413-429, 1992.
11. Liu B, Timar J, Hewlett J, Diglio CA, Honn EV: Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumour cells to endothelium via regulation of protein kinase C. Cell Reg 2: 1045-1055, 1992.
12. Pritchard GA and Mansel RE: The effects of essential fatty acids on the growth of breast cancer and melanoma. In: Omega-6 essential fatty acids Horrobin DF (Ed.), Wiley-Liss, New York pp379-390, 1990.
13. Van Der Merwe CF, Booyens J, Katzeff IE: Oral gamma linolenic acid in 21 patients with untreatable malignancy. Br J Clin Pract 41: 907-915, 1988.
14. McIlmurray M, Turkie W: Controlled trial of gamma linolenic acid in Dukes' C colorectal cancer. Br Med J 294: 1260, 1987.
15. Ramchurren N, Botha JH, Leary WP: An investigation in to the effects of gamma linolenic acid on murine sarcoma M52B. S Afr J Sci 81: 331, 1985.
16. Karmali RA, Marsh J, Fuchs C: Effects of dietary enrichment with gamma linolcnic acid upon growth of the R3230AC mammary adenocarcinoma. J Nutr Growth Cancer 2: 41-51, 1985.
17. Van Der Merwe CF, Booyens J, Joubert HF, Van Der Merwe CA: The effect of gamma-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver cancer: A double-blind placebo controlled trial. Prostag Leukot Essent Fatty Acids 40: 199-202, 1990.
18. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF and Puntis MCA: Inhibition of hepatocyte growth factor/scatter factor induced motility and invasion of human cancer cells by gamma linolenic acid. Br J Cancer 71: 744-752, 1995.
19. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE and Puntis MCA: Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid. Cancer Res 55: 5043-5048, 1995.
20. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
21. Hanks SK, Calalb MB, Harper MC, Patel SK: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 89: 8487-8491, 1992.
22. Schaller MD, Parsons JT: Focal adhesion kinase and associated proteins. Curr Opinion Cell Biol 6: 705-710, 1994.
23. FAK and paxillin induced by bombesin and endothelin. FEBS Lett 354: 315-319, 1994.
24. FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J Biol Chem 269: 27610-27617, 1994.
25. Furukawa T, Watanabe M, Kumota T, Dase S, Fujita S, Yamamoto T, Saikawa Y, Kuo TH, Tanino H, Kurihara N, Kawano Y, Kawamoto K, Suto A, Teramoto T, Ishibiki K and Kitajima M: Significance of in vitro attachment of human colon cancer to extracellular matrix proteins in experimental and clinical liver metastasis. J Surg Oncol 53: 10-16, 1993.
26. Hart IR, Goode NT and Wilson RE: Molecular aspects of the metastatic cascade. Biochim Biophys Acta 989: 65-84, 1989.
27. Liotta LA and Stracke ML: Tumor invasion and metastases: biochemical mechanisms. Cancer Treat Res 40: 223-238, 1988.
28. Jiang WG, Puntis MCA and Hallett MB: The molecular and cellular basis of cancer invasion and metastasis and its implications for treatment. Br J Surg 81: 1576-1590, 1994.
29. Vanwaes C, Surh DM, Chen Z, Kirby M, Rhim JS, Brager R: Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor. Cancer Res 55: 5434-5444, 1995.
30. Lessey BS, Albelda S, Buck CS, Castelbaum AJ, Yeh IT, Kohler M, Berchuck A: Distribution of integrin cell-adhesion molecules in endometrial cancer. Am J Pathol 146: 717-726, 1995.
31. Fujita S, Watanabe M, Kubota T, Teramoto T, Kitajima M: Alteration of expression in integrin beta (1)-subunit correlates with invasion and metastasis in colorectal-cancer. Cancer Lett 91: 145-149, 1995.
32. Plopper GE, McNamee HP, Dike LE, Bojanowski K and Ingber DE: Convergence of integrin and growth factor receptor signalling pathways with the focal adhesion complex. Mol Biol Cell 6: 1349-1365, 1995.
33. Arora PD, Ma J, Min W, Cruz T, McCulloch CAG: Interleukin-1 induced calcium in human fibroblasts is mediated through focal adhesions. J Biol Chem 270: 6042-6049, 1995.
34. D'Souza SE, Hinsberg MH and Plow EF: Arginyl-glycylsapartic acid (RGD): a cell adhesion motif. TIBS 16: 246-250, 1991.
35. Saiki I, Murata J, Matsuno K, Ogawa R, Nishi N, Tokura S, Azuma I: Anti-metastatic and anti-invasive effects of polymeric Arg-Gly-Asp (RGD) peptide, poly(RGD), and its analogues. Jpn J Cancer Res 81: 660-667, 1990.
36. Gehlsen KR, Argraves WS, Pierschbacher MD, Ruoslahti E: Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol 106: 925-930, 1988.
37. Soszka T, Knudsen KA, Beviglia L, Rossi C, Poggi A and Niewiarowski S: Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp Cell Res 196: 6-12, 1991.
38. Glukhova M, Koteliansky V, Sastre X, Thiery JP: Adhesion systems in normal breast and in invasive breast carcinoma. Am J Path 146: 706-716, 1995.
39. Weiner TM, Liu ET, Craven RJ, Cance WG: Expression of focal adhesion kinase gene and invasive cancer. Lancet 342: 1024-1025, 1993.